tiprankstipranks
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY
US Market
SHTDY
Sinopharm Group Co
RESEARCH TOOLSreports
Want to see SHTDY full AI Analyst Report?

Sinopharm Group Co (SHTDY) Income Statement

21 Followers

Sinopharm Group Co Income Statement

Last quarter (Q4 2025), Sinopharm Group Co's total revenue was ¥283.78B, a decrease of -4.00% from the same quarter last year. In Q4, Sinopharm Group Co's net income was ¥3.62B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 559.50B¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B
Gross Profit
¥ 40.09B¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B
Operating Expenses
¥ 23.88B¥ 28.07B¥ 28.30B¥ 26.83B¥ 24.34B
Depreciation and Amortization
¥ 4.17B¥ 2.36B¥ 4.43B¥ 4.17B¥ 3.92B
EBITDA
¥ 20.38B¥ 20.17B¥ 26.90B¥ 26.25B¥ 24.68B
Operating Income
¥ 16.21B¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B
Other Income/Expenses
¥ -1.82B¥ -2.19B¥ -697.06M¥ -2.04B¥ -2.71B
Pretax Income
¥ 14.40B¥ 14.00B¥ 19.51B¥ 18.56B¥ 17.00B
Net Income
¥ 6.96B¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B
Per Share Metrics
Basic EPS
¥ 11.10¥ 11.30¥ 14.50¥ 13.65¥ 12.45
Diluted EPS
¥ 11.10¥ 11.30¥ 14.50¥ 13.65¥ 12.45
Weighted Average Shares Outstanding
 624.11M 624.11M 624.13M 624.13M 622.23M
Weighted Average Shares Outstanding (Diluted)
 624.11M 624.11M 624.13M 624.13M 622.23M
Currency in CNY

Sinopharm Group Co Earnings and Revenue History